Still slogging through the research. I have noted in a study “ Chronic Methamptemanie increases A Syncuclein protein levels in the Striatum “ B. Butler et al 2014 states that chronic users have a 75 % chance of developing PD symptoms...so another possible avenue for PBT434
- Forums
- ASX - By Stock
- ATH
- PBT434 inhibits alpha- synuclein in the brain.
PBT434 inhibits alpha- synuclein in the brain., page-24
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ATH (ASX) to my watchlist
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.28M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $5.012K | 1.294M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
43 | 54662006 | 0.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.4¢ | 126993867 | 29 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
43 | 54662006 | 0.003 |
56 | 84698098 | 0.002 |
25 | 120860100 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.004 | 126993867 | 29 |
0.005 | 29734782 | 29 |
0.006 | 13206477 | 19 |
0.007 | 47601651 | 22 |
0.008 | 22833132 | 23 |
Last trade - 16.10pm 28/08/2024 (20 minute delay) ? |
Featured News
ATH (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online